SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Clinical trial NCT00113893 · COMPLETED

Trial details

NCT number: NCT00113893
Sponsor: Scios, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bone Marrow Diseases Myelodysplastic Syndromes Hematologic Diseases Bone Marrow Neoplasms

Start date: 2005-05-01
Primary completion: 2007-12-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.